Health First Patient Dosed in Clinical Study of Novel Cancer Therapy On July 9, 2025, Avenzo Therapeutics, Inc. announced that the first patient has been dosed in a Phase 1 clinical trial for AVZO-1418/DB-1418, a... Editorial1 day ago